Capacity Building on Managed Entry Agreements for Innovative Medicines


Following on from the European Commission's initiative to collect and analyse information about the Managed Entry Agreements (MEAs) used by EU Member States in a systematic way, the following survey has been prepared to assess the implementation and functioning of MEAs across Europe and in all therapeutic fields.
 
We would be grateful if you could complete the following surveys:

Survey 1:  Description of each MEA used in your country
This survey contains 10 on-line forms. The deadline is November 14

Survey 2: MEA for each therapeutic indication
This survey contains 20 on-line forms. The deadline is December 15

In both surveys, if the number of MEAs that you have implemented in your country is bigger that the one that the on-line survey contains, you will receive a message to contact with Panos Kanavos (p.g.kanavos@lse.ac.uk) or Jaime Espin (jaime@easp.es) to receive a Word/Excel file to fill in with the extra information

Take also into account that you may also save your survey at anytime while completing it and finish the remaining questions at a later time.

You can print your answers at the end of the survey.

Please do not hesitate to contact us if you have any problem
 
Panos Kanavos (LSE) and Jaime Espin (EASP)

EMINet